We are live on ! Find out more
COGT icon

Cogent Biosciences
COGT

135 hedge funds and large institutions have $859M invested in Cogent Biosciences in 2022 Q4 according to their latest regulatory filings, with 22 funds opening new positions, 53 increasing their positions, 37 reducing their positions, and 21 closing their positions.

New
Increased
Maintained
Reduced
Closed

4,929% more call options, than puts

Call options by funds: $704K | Put options by funds: $14K

43% more repeat investments, than reductions

Existing positions increased: 53 | Existing positions reduced: 37

5% more first-time investments, than exits

New positions opened: 22 | Existing positions closed: 21

1% more funds holding

Funds holding: 134 → 135 (+1)

8.57% less ownership

Funds ownership: 115.69% → 107.12% (-8.6%)

14% less funds holding in top 10

Funds holding in top 10: 7 → 6 (-1)

24% less capital invested

Capital invested by funds: $1.13B → $859M (-$270M)

Holders
135
Holders Change
+1
Holders Change %
+0.75%
% of All Funds
2.17%
Holding in Top 10
6
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-14.29%
% of All Funds
0.1%
New
22
Increased
53
Reduced
37
Closed
21
Calls
$704K
Puts
$14K
Net Calls
+$690K
Net Calls Change
-$418K

Top Buyers

1
RCM
RA Capital Management
Massachusetts
+$24.6M
2
Marshall Wace
Marshall Wace
United Kingdom
+$18.3M
3
LGM
Logos Global Management
California
+$13.6M
4
State Street
State Street
Massachusetts
+$10.6M
5
Citadel Advisors
Citadel Advisors
Florida
+$6.47M

Top Sellers

1
Janus Henderson Group
Janus Henderson Group
United Kingdom
-$22M
2
APM
Avidity Partners Management
Texas
-$20.3M
3
Balyasny Asset Management
Balyasny Asset Management
Illinois
-$15.7M
4
BI
BVF Inc
California
-$13.6M
5
CAM
Cormorant Asset Management
Massachusetts
-$6.82M
Name Holding Trade Value Shares
Change 		Change in
Stake
RCM
1
RA Capital Management
Massachusetts
$69.4M +$24.6M +1,986,028 +49%
BlackRock
2
BlackRock
New York
$57.2M +$4.34M +350,140 +8%
CC
3
Commodore Capital
New York
$49.9M – – –
State Street
4
State Street
Massachusetts
$49.3M +$10.6M +852,779 +25%
VA
5
VR Adviser
New York
$46.7M – – –
TCM
6
TCG Crossover Management
California
$42M +$1.86M +150,000 +4%
Vanguard Group
7
Vanguard Group
Pennsylvania
$40.1M +$3.49M +282,022 +9%
PA
8
Perceptive Advisors
New York
$37.1M – – –
DM
9
Deerfield Management
New York
$34.3M – – –
FFM
10
Fairmount Funds Management
Pennsylvania
$31.9M – – –
EAM
11
Eventide Asset Management
Massachusetts
$29.9M -$3.36M -271,114 -9%
FLSM
12
Frazier Life Sciences Management
California
$24.4M +$434K +35,000 +2%
VC
13
Vivo Capital
California
$23.1M +$1.38M +111,000 +6%
Citadel Advisors
14
Citadel Advisors
Florida
$21.4M +$6.47M +522,040 +39%
SCM
15
Suvretta Capital Management
New York
$20.9M -$635K -51,204 -3%
Janus Henderson Group
16
Janus Henderson Group
United Kingdom
$18.5M -$22M -1,774,861 -53%
Marshall Wace
17
Marshall Wace
United Kingdom
$17.1M +$18.3M +1,480,658 New
Geode Capital Management
18
Geode Capital Management
Massachusetts
$14.1M +$589K +47,570 +4%
Fidelity Investments
19
Fidelity Investments
Massachusetts
$13.2M -$1.95M -157,552 -12%
LGM
20
Logos Global Management
California
$12.7M +$13.6M +1,100,000 New
Adage Capital Partners
21
Adage Capital Partners
Massachusetts
$12M -$1.36M -110,037 -10%
CS
22
Candriam SCA
Luxembourg
$11.5M -$1.91M -154,361 -13%
BI
23
BVF Inc
California
$11.4M -$13.6M -1,100,000 -53%
CAM
24
Cormorant Asset Management
Massachusetts
$10.4M -$6.82M -550,000 -38%
GTC
25
Ghost Tree Capital
New York
$9.25M +$2.48M +200,000 +33%
1
2 3 4 5

COGT Hedge Fund Activity: Q4 2022 in Review

135 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in Cogent Biosciences (COGT) for Q4 2022, worth a combined $859M — down 24% from $1.13B a quarter earlier.

Buyers outnumbered sellers: 22 funds opened new COGT positions and 21 closed out — a net gain of 1 holder — while 53 added to existing stakes and 37 trimmed.

The largest buyer was RA Capital Management, adding an estimated $24.6M. The largest seller was Janus Henderson Group, cutting an estimated $22M.

  • 135 institutional investors held Cogent Biosciences (COGT) as of Q4 2022, up from 134 in Q3 2022.
  • Funds reported $859M of Cogent Biosciences stock for Q4 2022, down 24% quarter-over-quarter.
  • 22 funds opened new Cogent Biosciences positions in Q4 2022 and 21 closed out, a net change of +1 holder.
  • The largest Cogent Biosciences buyer in Q4 2022 was RA Capital Management, an estimated $24.6M added.
  • The largest Cogent Biosciences seller in Q4 2022 was Janus Henderson Group, an estimated $22M sold.

Based on aggregated 13F filings for Q4 2022.